Low count monoclonal B-cell lymphocytosis study
Part of Blood & lymphatic, Brain & nervous system, Cancer, Heart & circulation, Immune system & allergy, Infections, Mental health clinical trials.
This study looks at people with a small number of abnormal B-cells in their blood to understand if those cells increase the risk of developing blood cancers. If you're over 40 and haven't had a blood-related cancer diagnosis, you might be eligible to participate and help researchers learn more about this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over the age of 40.
- You have not been diagnosed with a lymphoproliferative disorder (a type of blood cancer).
- You are willing to have your blood tested or provide existing samples.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with certain slow-growing blood cancers (CLL/SLL, LPL/WM, and related conditions) to understand how they progress and what leads to needing treatment. It may help doctors predict changes over time and plan care more effectively.
This trial studies how the body makes blood cells in people with chronic lymphocytic leukemia (CLL), a related condition called monoclonal B-cell lymphocytosis (MBL), and in healthy volunteers matched by age. The goal is to understand differences that may help improve treatment or monitoring.
This study looks at families where more than one person has a blood cell disorder (lymphoproliferative disorder) to understand why it runs in families. If you or a relative have this condition, you may help researchers learn more about it.
This study looks at families where more than one close, blood-related person has a lymphoproliferative disorder (a group of conditions where the lymph system makes too many abnormal cells). It aims to better understand why these disorders run in families and how they may be inherited or related.
This study looks at certain markers on your blood cancer cells to understand them better. By joining, you help doctors learn more about your disease, which may guide future care.
This research study collects information from adults with chronic myelomonocytic leukemia (CMML), a rare blood cancer where the body makes too many monocytes (a type of white blood cell). By following patients over time, researchers aim to better understand the disease and improve treatments.
Hear when a new Monoclonal B-Cell Lymphocytosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.